ORIC
ORIC Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-02-07
Latest data update time: Updated on 2026-02-07
4.75 / 10Overall Score
NeturalInvestment Rating
4.75 / 10Overall Score
NeturalInvestment Rating
Should I Buy ORIC Now?
- Based on a composite score of 4.75/10, we rate ORIC as a Netural. Our analysis breaks down into 2.75/10 for Fundamentals, 6.38/10 for Technicals, and 4.92/10 for Sentiment, indicating the stock is likely to consolidate sideways.
What is the current technical signals for ORIC?
Is ORIC fundamentally strong?
What is the market sentiment for ORIC?
Should I Buy ORIC Now?
- Based on a composite score of 4.75/10, we rate ORIC as a Netural. Our analysis breaks down into 2.75/10 for Fundamentals, 6.38/10 for Technicals, and 4.92/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is ORIC fundamentally strong?
What is the current technical signals for ORIC?
What is the market sentiment for ORIC?
